Evidence map›Paper›PMID 38713747›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

A Composite Hydrogel Functionalized by Borosilicate Bioactive Glasses and VEGF for Critical-Size Bone Regeneration.

Chao Huang, Shun Shi, Muyan Qin, Xiao Rong, Zichuan Ding, Xiaoxue Fu, Weinan Zeng, Lei Luo, Deping Wang, Zeyu Luo and 2 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chao HuangDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.ORCID 0000-0002-7140-3304
Shun ShiCollege of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, Sichuan, 610065, P. R. China.
Muyan QinSchool of Materials Science and Engineering, Tongji University, Shanghai, 201804, P. R. China.
Xiao RongDepartment of Ultrasound, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Zichuan DingDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Xiaoxue FuDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Weinan ZengDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Lei LuoWest China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Deping WangSchool of Materials Science and Engineering, Tongji University, Shanghai, 201804, P. R. China.
Zeyu LuoDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Yiwen LiCollege of Polymer Science and Engineering, State Key Laboratory of Polymer Materials Engineering, Sichuan University, Chengdu, Sichuan, 610065, P. R. China.
Zongke ZhouDepartment of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.ORCID 0000-0002-9037-4756

Funding

Fundamental Research Funds for the Central Universities 2021SCU12043Miaozi Project in Science and Technology Innovation Program of Sichuan Province MZGC20230023National Natural Science Foundation of China 52225311National Natural Science Foundation of China 82172394National Natural Science Foundation of China 82272483National Natural Science Foundation of China U22A20280Natural Science Foundation of Sichuan 2022NSFSC1445Sichuan University Postdoctoral Interdisciplinary Innovation FundWest China Nursing Discipline Development Special Fund Project, Sichuan University HXHL20003
6 · The paper itself

Abstract

Critical-size bone defects pose a formidable challenge in clinical treatment, prompting extensive research efforts to address this problem. In this study, an inorganic-organic multifunctional composite hydrogel denoted as PLG-g-TA/VEGF/Sr-BGNPs is developed, engineered for the synergistic management of bone defects. The composite hydrogel demonstrated the capacity for mineralization, hydroxyapatite formation, and gradual release of essential functional ions and vascular endothelial growth factor (VEGF) and also maintained an alkaline microenvironment. The composite hydrogel promoted the proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells (rBMSCs), as indicated by increased expression of osteogenesis-related genes and proteins in vitro. Moreover, the composite hydrogel significantly enhanced the tube-forming capability of human umbilical vein endothelial cells (HUVECs) and effectively inhibited the process of osteoblastic differentiation of nuclear factor kappa-B ligand (RANKL)-induced Raw264.7 cells and osteoclast bone resorption. After the implantation of the composite hydrogel into rat cranial bone defects, the expression of osteogenic and angiogenic biomarkers increased, substantiating its efficacy in promoting bone defect repair in vivo. The commendable attributes of the multifunctional composite hydrogel underscore its pivotal role in expediting hydrogel-associated bone growth and repairing critical bone defects, positioning it as a promising adjuvant therapy candidate for large-segment bone defects.

Indexed as

Bone RegenerationHydrogelsOsteogenesisVascular Endothelial Growth Factor AAnimalsCell DifferentiationCell ProliferationDisease Models, AnimalGlassHumansHuman Umbilical Vein Endothelial CellsMaleMesenchymal Stem CellsMiceRatsRats, Sprague-DawleyHydrogelsSilicatesVascular Endothelial Growth Factor Aangiogenesisbioactive glassbone regenerationhydrogelosteogenic differentiationVEGF

Identifiers

PMID38713747
PMCPMC11234436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.